1. Home
  2. MNMD vs COFS Comparison

MNMD vs COFS Comparison

Compare MNMD & COFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • COFS
  • Stock Information
  • Founded
  • MNMD 2019
  • COFS 1898
  • Country
  • MNMD United States
  • COFS United States
  • Employees
  • MNMD N/A
  • COFS N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • COFS Major Banks
  • Sector
  • MNMD Health Care
  • COFS Finance
  • Exchange
  • MNMD Nasdaq
  • COFS Nasdaq
  • Market Cap
  • MNMD 509.2M
  • COFS 448.8M
  • IPO Year
  • MNMD N/A
  • COFS N/A
  • Fundamental
  • Price
  • MNMD $9.22
  • COFS $30.75
  • Analyst Decision
  • MNMD Strong Buy
  • COFS Strong Buy
  • Analyst Count
  • MNMD 7
  • COFS 2
  • Target Price
  • MNMD $24.71
  • COFS $39.00
  • AVG Volume (30 Days)
  • MNMD 1.2M
  • COFS 62.7K
  • Earning Date
  • MNMD 11-06-2025
  • COFS 10-22-2025
  • Dividend Yield
  • MNMD N/A
  • COFS 3.64%
  • EPS Growth
  • MNMD N/A
  • COFS N/A
  • EPS
  • MNMD N/A
  • COFS 1.30
  • Revenue
  • MNMD N/A
  • COFS $108,378,000.00
  • Revenue This Year
  • MNMD N/A
  • COFS $77.76
  • Revenue Next Year
  • MNMD N/A
  • COFS $8.17
  • P/E Ratio
  • MNMD N/A
  • COFS $23.70
  • Revenue Growth
  • MNMD N/A
  • COFS 30.36
  • 52 Week Low
  • MNMD $4.70
  • COFS $24.89
  • 52 Week High
  • MNMD $11.02
  • COFS $38.15
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 47.40
  • COFS 57.28
  • Support Level
  • MNMD $8.70
  • COFS $30.19
  • Resistance Level
  • MNMD $9.30
  • COFS $31.35
  • Average True Range (ATR)
  • MNMD 0.58
  • COFS 0.52
  • MACD
  • MNMD -0.13
  • COFS 0.02
  • Stochastic Oscillator
  • MNMD 22.41
  • COFS 66.29

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About COFS ChoiceOne Financial Services Inc.

ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.

Share on Social Networks: